openPR Logo
Press release

Parp Inhibitor Market Set to Witness Significant Growth by 2025-2032 | AstraZeneca, GlaxoSmithKline, Merck Co. & Inc

04-09-2025 02:15 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Parp Inhibitor Market

Parp Inhibitor Market

Global PARP inhibitor market is estimated to be valued at USD 7.85 Bn in 2025 and is expected to reach USD 14.36 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.0% from 2025 to 2032.

The Parp Inhibitor Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Parp Inhibitor Market, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry players, helping them make informed decisions and stay ahead of the competition in a rapidly evolving market landscape. With its comprehensive coverage and actionable insights, the Parp Inhibitor Market Report offers unparalleled opportunities for growth and success in the industry.

The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. Parp Inhibitor Market has been expanding significantly in recent years, driven by various key factors like increased demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of Parp Inhibitor Market, including market size, trends, drivers and constraints, competitive aspects, and prospects for future growth.

Get a Sample Copy of This Report@ https://www.coherentmarketinsights.com/insight/request-sample/3037

🎯 Scope of Parp Inhibitor Market Report:

The Parp Inhibitor Market Report presents a detailed analysis of trends, drivers, and challenges within the industry. It includes thorough insights into market segmentation by product type, application, and geography.The report highlights major players and their competitive strategies, as well as emerging opportunities for growth.It also investigates consumer behavior and preferences that affect market dynamics. Forecasts for market size and growth potential in the upcoming years are included, backed by quantitative data. It also addresses regulatory factors and technological advancements influencing the market, making this report a valuable resource for stakeholders looking to make informed business decisions.

⏩ Key Highlights of Parp Inhibitor Market Research Report:

Β» Comprehensive analysis of the Parp Inhibitor Market.
Β» Identification of market size and growth trends.
Β» Competitive landscape assessment, including key players and their strategies.
Β» Consumer behavior insights related to Parp Inhibitor usage.
Β» Emerging trends and opportunities in the Parp Inhibitor Market.
Β» Regional analysis, highlighting variations in Parp Inhibitor usage and competition.
Β» Industry best practices for effective Parp Inhibitor optimization.
Β» Future outlook and market projections for informed decision-making.

πŸ“Œ Key players Highlighted in This Report:

β€’ AstraZeneca
β€’ GlaxoSmithKline
β€’ Merck Co. & Inc
β€’ GlaxoSmithKline plc
β€’ AbbVie Inc
β€’ Clovis Oncology
β€’ Medivation
β€’ Johnson & Johnson Services
β€’ Inc
β€’ Pfizer Inc.
β€’ Repare Therapeutics Inc.
β€’ Genentech Inc.
β€’ Artios Pharma
β€’ Repare Therapeutics Inc.
β€’ Sierra Oncology Inc.
β€’ KaryopharmTherapeutics Inc.
β€’ Ono Pharmaceutical Co., Ltd.,
β€’ Jiangsu Hengrui Medicine Co., Ltd.,

⏩ Comprehensive segmentation and classification of the report:

β€’ By Drug Type: Niraparib, Olaparib, Rucaparib, Talazoparib, Veliparib, Others
β€’ By Application: Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others
β€’ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

πŸ“ By Regions and Countries

β—˜ North America (U.S., Canada, Mexico)
β—˜ Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
β—˜ Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
β—˜ South America (Brazil, Argentina, Rest of SA)
β—˜ Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Get discount on Purchase report@ https://www.coherentmarketinsights.com/insight/buy-now/3037

πŸ“Œ Key Benefits for Stakeholders

✦ Quantitative analysis of market segments, trends, estimations, and dynamics (2025-2032).
✦ Insights into key drivers, restraints, and opportunities.
✦ Porter's Five Forces analysis for strategic decision-making.
✦ Segmentation analysis to identify market opportunities.
✦ Revenue mapping of major countries by region.
✦ Benchmarking and positioning of market players.
✦ Analysis of regional and global trends, key players, and growth strategies.

⏩ Reasons to Purchase the Report

πŸ‘‰ Strategic Competitor Insights: Gain critical information and analysis on key competitors to develop effective sales and marketing strategies.
πŸ‘‰ Identify Emerging Players: Discover new entrants with promising product portfolios and formulate counter-strategies to enhance your competitive edge.
πŸ‘‰ Target Client Identification: Classify potential new clients or partners within your target demographic for better market penetration.
πŸ‘‰ Tactical Initiative Development: Understand the focal areas of leading companies to craft informed tactical initiatives.
πŸ‘‰ Mergers and Acquisitions Planning: Make strategic decisions regarding mergers and acquisitions by pinpointing top manufacturers in the market.
πŸ‘‰ Licensing Strategy Development: Identify prospective partners with attractive projects to create robust in-licensing and out-licensing strategies, thereby enhancing business potential.
πŸ‘‰ Support for Presentations: Utilize reliable, high-quality data and analysis to strengthen your internal and external presentations.
This report provides actionable growth insights through a comprehensive analysis that includes secondary research, primary interviews with industry stakeholders and competitors, as well as validation and triangulation using the Coherent Market Insights regional database. Experts have meticulously compiled primary data from market participants across the value chain in all regions, along with insights from industry specialists, to deliver both qualitative and quantitative findings.

πŸ“ Table of Contents:

Parp Inhibitor Market scenario 2025

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Parp Inhibitor Market
Chapter 2: Exclusive Summary - the basic information of the Parp Inhibitor Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Parp Inhibitor
Chapter 4: Presenting the Parp Inhibitor Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2025 - 2032
Chapter 6: Evaluating the leading manufacturers of the Parp Inhibitor Market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2025-2032)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Get Instant Access! Purchase Research Report and Receive a 25% Discount with limited-time offer! https://www.coherentmarketinsights.com/insight/buy-now/3037

πŸ’¬ FAQ's

Q.1 What are the main factors influencing the Parp Inhibitor market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Parp Inhibitor Market companies compare in terms of sales, revenue, and prices?
Q.5 How are market types and applications and deals, revenue, and value explored?
Q.6 What does a business area's assessment of agreements, income, and value implicate?

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

☎️ Contact Us:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parp Inhibitor Market Set to Witness Significant Growth by 2025-2032 | AstraZeneca, GlaxoSmithKline, Merck Co. & Inc here

News-ID: 3963370 • Views: …

More Releases from Coherent Market Insights

Asia Pacific Wound Care Biologics Market Growth in Future Scope 2025-2032 | Smith & Nephew Plc β€’ Organogenesis Inc. β€’ Integra LifeSciences Holdings Corporation
Asia Pacific Wound Care Biologics Market Growth in Future Scope 2025-2032 | Smit …
The Asia Pacific Wound Care Biologics market is estimated to be valued at USD 296.1 Mn in 2025 and is expected to reach USD 533.8 Mn by 2032, growing at a compound annual growth rate CAGR of 7.6% from 2025 to 2032. ➀ The qualitative latest Research report (2025-2032) on the Asia Pacific Wound Care Biologics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges,…
Future Scope of Premium Potting Soils Market Set for Significant Growth by 2025 - Comprehensive Competitive Landscape Through 2032
Future Scope of Premium Potting Soils Market Set for Significant Growth by 2025 …
The Premium Potting Soils market is estimated to be valued at USD 1,598.4 Mn in 2025 and is expected to reach USD 1,855.1 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from 2025 to 2032. ➀ The Latest Report, titled Premium Potting Soils Market includes a detailed analysis of current market conditions, market players, regions, types, applications, Opportunity and Forecast 2025-2032. The report provides a detailed…
Sustained Release Coating Market Set for Booming Growth from 2025 to 2032 | Coating Place Inc. β€’ Panchsheel Organics Ltd. β€’ Eastman Chemical Company
Sustained Release Coating Market Set for Booming Growth from 2025 to 2032 | Coat …
The Sustained Release Coating market is estimated to be valued at USD 508.2 Mn in 2025 and is expected to reach USD 794.9 Mn by 2032, growing at a compound annual growth rate CAGR of 6.6% from 2025 to 2032. ➀ The latest report from Coherent Market Insights examines the growth prospects of the Sustained Release Coating Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business…
Asia Pacific Cycling Wear Market is Going to Boom: Strategic Insights and Growth Opportunities with Key Players like JRD Cycling β€’ Castelli Cycling β€’ Giro Sport Design β€’ Champion System β€’ Conquest Cycle Wear Ltd.
Asia Pacific Cycling Wear Market is Going to Boom: Strategic Insights and Growth …
The Asia Pacific Cycling Wear market is estimated to be valued at USD 1,388.6 Mn in 2025 and is expected to reach USD 2,585.1 Mn by 2032, growing at a compound annual growth rate CAGR of 7.0% from 2025 to 2032. ➀ This report on the Asia Pacific Cycling Wear market offers an comprehensive analysis of the current trends, market size, and projections up to 2032. Combining qualitative and quantitative insights,…

All 5 Releases


More Releases for Parp

PARP Inhibitors Market to Surpass USD 12 Billion by 2034,
Introduction Cancer continues to be one of the most pressing healthcare challenges worldwide, and the demand for targeted, effective therapies has never been greater. Among the most promising innovations are Poly (ADP-ribose) polymerase (PARP) inhibitors, a class of drugs designed to exploit DNA repair weaknesses in cancer cells, particularly those with BRCA1/2 mutations. By preventing cancer cells from repairing DNA damage, PARP inhibitors lead to cell death, offering a new line…
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8…
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA. Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html Global PARP Inhibitors Market: Competition Landscape Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is…
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib. The report analyses the global Lynparza market in detail along with the regional analysis as…